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Abstract 
Background: Schistosomiasis control programmes primarily use school-based surveys to identify areas for mass drug 
administration of preventive chemotherapy. However, as the spatial distribution of schistosomiasis can be highly focal, 
transmission may not be detected by surveys implemented at districts or larger spatial units. Improved mapping strate-
gies are required to accurately and cost-effectively target preventive chemotherapy to remaining foci across all possible 
spatial distributions of schistosomiasis.
Methods: Here, we use geostatistical models to quantify the spatial heterogeneity of Schistosoma haematobium and S. 
mansoni across sub-Saharan Africa using the most comprehensive dataset available on school-based surveys. Applying this 
information to parameterise simulations, we assess the accuracy and cost of targeting alternative implementation unit sizes 
across the range of plausible schistosomiasis distributions. We evaluate the consequences of decisions based on survey 
designs implemented at district and subdistrict levels sampling different numbers of schools. Cost data were obtained 
from field surveys conducted across multiple countries and years, with cost effectiveness evaluated as the cost per correctly 
identified school.
Results: Models identified marked differences in prevalence and spatial distributions between countries and species; 
however, results suggest implementing surveys at subdistrict level increase the accuracy of treatment classifications 
across most scenarios. While sampling intensively at the subdistrict level resulted in the highest classification accuracy, 
this sampling strategy resulted in the highest costs. Alternatively, sampling the same numbers of schools currently 
recommended at the district level but stratifying by subdistrict increased cost effectiveness.
Conclusions: This study provides a new tool to evaluate schistosomiasis survey designs across a range of transmis-
sion settings. Results highlight the importance of considering spatial structure when designing sampling strategies, 
illustrating that a substantial proportion of children may be undertreated even when an implementation unit is 
correctly classified. Control programmes need to weigh the increased accuracy of more detailed mapping strategies 
against the survey costs and treatment priorities.
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Introduction
Schistosomiasis is a chronic parasitic disease with sub-
stantial public health impacts globally. The majority of 
the burden occurs in sub-Saharan Africa, with over 150 
million individuals estimated to be infected with either 
Schistosoma haematobium or S. mansoni [1]. Determined 
by the distribution of and contact with freshwater snail 
habitats and access to clean water and sanitation, schis-
tosomiasis transmission is highly focal, with disease risks 
varying markedly within small spatial areas [2, 3]. This 
spatial heterogeneity has become more pronounced as 
prevalence decreases due to highly successful control 
programmes [4]. New strategies are required to identify 
and target remaining foci of infection in order to achieve 
elimination goals, including re-evaluating the spatial 
units at which control programmes operate.
Preventive chemotherapy with praziquantel remains 
the cornerstone of schistosomiasis control programmes 
[4, 5]. Mass drug administration targets high risk groups 
living in endemic areas, including school aged children 
(SAC, ages 5–14 years), pregnant women and individuals 
with occupational risks [6]. Prior to treatment, epidemio-
logical data on infection prevalence are required to iden-
tify high-risk communities within geographically suitable 
regions; prevalence is assessed, and treatment assigned at 
a spatial unit referred to as the implementation unit (IU). 
Although there is no standard definition for IUs, these 
are typically defined as districts or ecological zones con-
sisting of multiple subdistricts [7]. Current World Health 
Organization (WHO) guidelines recommend purpose-
fully selecting sites in high prevalence areas. In practice, 
most countries identify high prevalence regions and esti-
mate prevalence using two-stage cluster-based school 
surveys, sampling 50 children per school for up to five 
schools per IU [6, 7]. This survey design is easily imple-
mented and analysed, using simple random sampling 
from lists of schools per IU without requiring additional 
fine-scale spatial information on schistosomiasis distri-
bution. Based on these surveys, preventive chemother-
apy is administered every year for mapping units with 
over 50% prevalence, every two years if the prevalence 
is between 10–50% and every three years if prevalence 
is below 10% [6]. These guidelines are currently under 
review by a WHO working group; although no official 
guidelines have been finalised, forthcoming guidelines 
are likely to specify a single 10% threshold determining 
annual treatment [8]. As countries move towards elimi-
nation and schistosomiasis transmission becomes more 
focal, there is increasing recognition of the need to imple-
ment treatment policies at lower administrative levels [9]. 
Previous studies have demonstrated a substantial propor-
tion of schools are misclassified and incorrectly treated, 
due to variation within districts [10]. The rollout of these 
new guidelines makes this an opportune time to evaluate 
potential sampling and treatment strategies implemented 
at district or subdistrict levels [11].
Determining an optimal sampling strategy requires 
balancing trade-offs between accuracy and cost to deter-
mine where preventive chemotherapy should be targeted. 
Simulations are frequently used to assess how alternative 
sampling strategies can improve estimates of prevalence 
and maximise cost efficiency by more accurately target-
ing preventive chemotherapy [12–15]. Using geostatisti-
cal simulations of baseline prevalence estimated from 
existing survey data, effects of different sampling strate-
gies can be evaluated against known parameters gen-
erated from spatially realistic simulated datasets. This 
allows assessment of a wide range of sampling designs 
across different prevalence distributions. For schisto-
somiasis, this approach has been used to explore the 
accuracy and cost effectiveness of varying the number of 
schools and number of children sampled under current 
two-stage cluster design surveys [16]. Additionally, a pre-
vious study explored the performance of two sampling 
strategies for classifying school-level schistosomiasis 
prevalence: lot quality assurance sampling (LQAS), sam-
pling small numbers of children from all schools within 
a given area, and model-based geostatistical approaches, 
using spatial modelling approaches to predict prevalence 
based on a small number of sampled schools [12].
Here, we use geostatistical simulations to evaluate 
potential survey sampling strategies across a range of 
plausible spatial distributions of S. haematobium and S. 
mansoni prevalence. We compare two-stage cluster sur-
vey designs implemented at district and subdistrict lev-
els sampling different numbers of schools. We aim to 
(i) quantify the spatial heterogeneity of schistosomiasis 
across sub-Saharan Africa; (ii) evaluate the accuracy of 
survey designs across this range of parameters; and (iii) 
assess the cost implications of survey designs. Together, 
this allows identification of optimal survey designs across 
spatially heterogenous distributions of disease.
Methods
To evaluate sampling strategies across all possible distri-
butions of schistosomiasis in SSA, we first fitted country 
and species-specific geostatistical models to characterise 
the spatial heterogeneity of schistosomiasis. These mod-
els were then used to parameterise simulations in a rep-
resentative, hypothetical country in SSA, capturing the 
full range of possible transmission scenarios. Alternative 
sampling strategies were assessed based on the overall 
accuracy, numbers of schools correctly and incorrectly 
treated as well as estimated cost implications.
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Country‑level geostatistical analysis
To estimate the spatial distribution of schistosomiasis, we 
obtained data on schistosomiasis surveys from the WHO 
Expanded Special Project for Elimination of Neglected 
Tropical Diseases (ESPEN) portal [17]. This represents 
the largest and most geographically comprehensive data-
base of schistosomiasis surveys. We assembled data for 
all georeferenced school-based surveys of school-age 
children in SSA. To exclude survey points with inaccu-
rate spatial data, we removed all surveys with duplicate 
locations reported within the same year and surveys 
with coordinates reported outside the district or admin-
istrative unit of the named school/site. We additionally 
excluded survey points reporting only a prevalence rather 
than the numbers of children sampled and detected posi-
tive. We then excluded schools reporting over 100 chil-
dren sampled as these were not representative of typical 
survey methodology and potentially reflected aggregated 
data. In line with current WHO guidelines, we defined 
S. haematobium using urine filtration and S. mansoni 
infections diagnosed using Kato-Katz techniques. For 
countries with repeated survey data reported for multiple 
years, we included only the most recent survey. Coun-
tries with less than 50 survey points were excluded from 
further analysis.
From this dataset, we fitted binomial geostatistical 
models to schistosomiasis data. Models were fitted sep-
arately for each country and species, with no additional 
covariates included. The number of individuals, Yi, who 
tested positive for schistosomiasis out of the total num-
ber of individuals examined, ni, at location xi was consid-
ered as the realisation of a binomial random variable Yi ~ 
Binomial(ni, p(xi)), with p(xi) modelled as:
where μ is the intercept, S(xi) is a zero mean Gaussian 
process with variance σ2 and an exponential correlation 
function given by ρ(k; φ) = exp{-k/ φ} where φ > 0 is a 
scale parameter that controls the extent of spatial corre-
lation and k is the distance between two sampling loca-
tions; and Zi is a set of independent zero-mean Gaussian 
variables with variance τ2. Models were fitted using 
Monte Carlo maximum likelihood estimation imple-
mented in R [18].
Schistosomiasis prevalence simulations
As we wanted to evaluate survey strategies for all pos-
sible schistosomiasis distributions, we chose to simulate 
prevalence within a hypothetical representative country 
rather than using data for single countries. We assigned 






= µ+ S(xi)+ Zi
country area of all countries in SSA  (km2). We used the 
median ratio of numbers of district level IUs to country 
area in SSA to determine the number of districts. Esti-
mating five subdistricts per IU on average, we randomly 
assigned districts and subdistricts, with all districts com-
prised of 5 subdistricts. The final country had district and 
subdistrict sizes comparable to the average geographical 
sizes observed across SSA countries. As our simulated 
country had a similar area to Uganda, we distributed 
schools based on the density of schools within Uganda, 
assuming 500 SAC per school and at least 5 schools per 
district, leading to a total estimate of 15,000 schools 
countrywide (Additional file 1: Figure S2).
To capture heterogeneity of the spatial variability and 
spatial extent of schistosomiasis across SSA, we com-
bined parameters from all geostatistical models to gen-
erate gold-standard prevalence distributions. For each 
species, we defined schistosomiasis using all possible 
combinations of the median, 25th and 75th percentile 
of country level parameters fitted from geostatistical 
models, across deciles of mean prevalence. This allowed 
simulations of prevalence surfaces capturing all possible 
scenarios with the full range of prevalence levels, spa-
tial variances and scales. For each combination of model 
parameters, we conducted 100 unconditional simulations 
of the number of SAC positive in all schools within the 
hypothetical country.
Evaluation of alternate survey designs
Using these simulations, we assessed different sur-
vey designs. These included: (i) sampling 5 randomly 
selected schools per district, with the IU defined as a 
district (existing sampling strategy); (ii) sampling 5 ran-
domly selected schools per subdistrict, using subdistrict 
as the IU; and (iii) sampling 1 randomly selected school 
per subdistrict, with IU defined as a subdistrict. For all 
sampling strategies, we sampled 50 randomly selected 
SAC per selected school. As per current guidelines, we 
used the mean prevalence per IU to determine whether 
the school was above or below a threshold. To evaluate 
survey designs, we compared the survey classification 
of the IU to the gold standard classification calculated 
from the mean prevalence of all schools within the IU. 
Survey designs were assessed based on overall accuracy 
of treatment classifications (at the level of the IU) as well 
as the proportions of schools over or undertreated (given 
school-level prevalence) using the resulting assigned IU 
treatment classification. We additionally compared the 
survey accuracy, with parameters defining the spatial 
distribution of schistosomiasis, to determine how survey 
performance varied across transmission settings.
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Cost analysis
As more intensive sampling may give more accurate 
results but be prohibitively expensive, we additionally 
assessed the cost of all survey designs. Survey design 
costs were estimated using the ingredients method 
using capital resources data obtained from school-based 
mapping surveys [16]. We considered only financial 
costs and excluded expenditures related to general pro-
gramme operating costs or costs borne by the beneficiar-
ies. Expenditures related were extracted for five annual 
Fig. 1 Distribution of school-based surveys included in the analysis
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programmatic surveys, including surveys conducted 
in 2016–2017 in Malawi and Uganda and surveys con-
ducted in 2017–2018 in Tanzania, Malawi and Uganda 
(SCI, financial expenditure records). We calculated the 
mean costs per school surveyed separately for each of the 
five available surveys, using the median cost from all sur-
vey data to evaluate cost effectiveness. Consumable item 
costs were calculated based on the quantity used for each 
diagnostic method and number of children surveyed, 
assuming 10% wastage. We defined capital items as items 
with a typical life expectancy of over one year; the costs 
of these items were annuitized based on the useful life 
expectancy in years.
We assumed an average of one school per day would be 
visited by the survey team, including a half day to regis-
ter children and collect samples and a half day of sample 
processing. Based on reported survey activities, teams 
included one driver, one team leader, one district officer 
and one central officer with three technicians would be 
required to sample 50 children. Per diems for sample 
teams were estimated based on reported country spe-
cific expenditures. We calculated mean costs per school 
based on reported district level fuel costs and numbers of 
schools covered, assuming vehicle maintenance was con-
ducted once during the survey period. No capital costs 
for vehicle purchase were included. All costs were con-
verted into US dollars (USD) using the Consumer Price 
Index and current exchange rates. Cost effectiveness was 
evaluated based on the cost per school assigned to the 
correct treatment category using the median survey cost 
per school. This definition of cost effectiveness prioritises 
classification accuracy, weighting schools not requir-
ing treatment and requiring treatment equally. However, 
alternatively, control programmes may prioritise ensur-
ing all schools above the prevalence threshold receive 
treatment. To address this priority, we additionally evalu-
ated the cost per school requiring treatment which was 
adequately treated.
Results
We fitted geostatistical models for S. haematobium 
prevalence in 24 countries and S. mansoni in 28 coun-
tries across SSA (Fig.  1). This dataset included results 
from 23,722 school-based surveys, with the numbers of 
schools sampled per country ranged from 64 to 1838 for 
S. haematobium and 64 to 2230 for S. mansoni (Addi-
tional file 1: Figure S1). For S. haematobium, the median 
school-level prevalence was 0.02 (interquartile range, 
IQR: 0–0.12), with 3039 of the 10,316 schools sampled 
(29.5%) reporting a prevalence of 10% or higher (Fig. 2). 
Median prevalence of S. mansoni was 0.00 (IQR 0–0.04) 
with only 2529 of 13,406 schools sampled (18.9%) exceed-
ing the 10% threshold. For both species, the median num-
ber of children sampled per school was 50 (IQR: 30–50). 
Spatial patterns of prevalence varied markedly between 
countries and species surveyed, with φ ranging from 0.07 
to 146.44 km (mean: 73.30 km) for S. haematobium and 
0.0048 to 696.13 km (mean: 109.23 km). Similarly, both 
spatial variance (τ2) and nonspatial variance (σ2) differed 
by country and species (Fig. 3, Additional file 1: Table S1).
Using these models, we generated prevalence surfaces 
across our simulated country, representing plausible 
Fig. 2 Average district prevalence and distribution of included schools with prevalence below 10% for all surveys included for S. haematobium (a) 
and S. mansoni (b)
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spatial distributions of infections. From country-specific 
geostatistical models, we used the median, 25th and 75th 
quartiles for all possible combinations of model param-
eters φ, τ2 and σ2 with µ ranging from 0.0005 to 0.207 
(Table  1). This generated 297 unique scenarios each for 
S. haematobium and S. mansoni. These scenarios repre-
sented all possible distributions of prevalence with differ-
ent levels of spatial and nonspatial variance and ranges of 
spatial correlation across a simulated country (Fig. 4).
Across these scenarios, the currently used protocol 
randomly sampling 5 schools with the IU defined at dis-
trict level correctly classified a median of 86.7% (IQR: 
83.4–90.3%) of districts for S. haematobium and 93.9% 
(IQR: 89.1–98.2%) of districts for S. mansoni. However, 
within these districts, only a median of 73.4% (IQR: 68.0–
81.4%) and 89.2% (IQR: 80.1–96.3%) of schools were 
assigned to the correct treatment category for S. haema-
tobium and S. mansoni, respectively. In contrast, defining 
the IU at subdistrict level and sampling 5 schools per IU 
correctly classified a slightly higher proportion of IUs, 
with a median of 89.8% (IQR: 86.9–92.1%) and 89.6% 
(IQR: 87.2–91.1%) subdistricts correctly classified for S. 
haematobium and S. mansoni. Similarly, within classified 
subdistricts, a higher proportion of schools were cor-
rectly classified, with 78.7% (IQR: 73.3–84.7%) and 75.7% 
(IQR: 70.9–79.3%) assigned the correct treatment cat-
egory for S. haematobium and S. mansoni (Fig. 5).
Due to the intensity of sampling required to survey 5 
schools per subdistrict, we additionally evaluated a more 
realistic scenario sampling one school per subdistrict, 
sampling the same total number of schools as the cur-
rent sampling approach of 5 schools per district. This 
slightly decreased the treatment classification accuracy 
for subdistrict level IUs, with the median probability of 
correctly classifying a subdistrict of 79.9% (IQR: 74.6–
85.4%) and 91.7% (IQR: 85.7–96.6%) for S. haematobium 
and S. mansoni (Fig. 5). This led to treatment being cor-
rectly assigned to 75.2% (IQR: 69.5–82.2%) of schools for 
S. haematobium and 89.5% (IQR: 82.8–95.4%) of schools 
for S. mansoni. Comparing this sampling strategy to the 
current district level sampling strategy demonstrated 
that even sampling only one school per subdistrict still 
consistently resulted in a higher proportion of schools 
receiving the correct treatment for all but the lowest 
prevalence settings. Despite the overall accuracy, sam-
pling more intensively at subdistrict level substantially 
decreased the number of undertreated schools when 
compared to sampling only one school per subdistrict 
(Fig.  6a, b). Any sampling strategy implemented at sub-
district level consistently decreased the number of over-
treated schools (Fig.  6c, d). The treatment classification 
accuracy of all sampling strategies varied by schistoso-
miasis prevalence, with the lowest accuracy observed 
when prevalence approached the 10% threshold. Over-
all, increased focality (as represented by φ) resulted in 
increases in the numbers of schools over or undertreated 
for both species. Similarly, the accuracy of treatment 
classifications decreased with increasing spatial variance 
(τ2) and nonspatial variance (σ2). These effects were more 
pronounced when the mean prevalence approached the 
10% threshold.
As the feasibility of these survey methods is largely 
dependent on total costs, we compared the total costs of 
each survey approach. Median estimated costs per school 
were USD 779.90 (IQR: USD 770.30–807.70) for schools 
surveyed with both urine filtration and Kato-Katz diag-
nostics, with median costs of USD 714.00 (IQR: USD 
708.80–749.90) for schools surveyed using only urine 
filtration and USD 308.30 (IQR: USD 287.00–342.30) 
for schools surveyed using only Kato-Katz. In addition 
to being highly sensitive to the diagnostic method used, 
the majority of remaining costs were due to personnel 
costs (Additional file  1: Tables S2, S3). Although both 
sampling 5 schools per district and sampling 1 school per 
subdistrict resulted in the same number of schools and 
total costs within this scenario, the median costs per cor-
rectly classified school were slightly lower for both spe-
cies when 1 school was sampled per subdistrict (Table 2). 
Sampling 5 schools per subdistrict resulted in the highest 
survey costs per correctly classified school. Similar trends 
were observed for costs per adequately treated school.
Discussion
Identifying and targeting mass drug administration to the 
most needed areas while minimising costs is a key prior-
ity for schistosomiasis control programmes. This study 
demonstrates the trade-offs control programmes are 
faced with when conducting mapping surveys to deter-
mine schistosomiasis treatment. A wide range of spatial 
patterns of both schistosomiasis species were identified 
across SSA, as expected, due to the diverse environments 
and health programmes within this region. For all of the 
varied schistosomiasis distributions assessed, using sub-
district level IUs consistently increases accuracy of both 
the IU level classification and the proportions of schools 
assigned to the correct treatment category. This analysis 
additionally illustrates how substantial proportions of 
schools may be undertreated, even when the IU is cor-
rectly classified, highlighting how the spatial structure 
impacts school-level classification accuracy. However, 
depending on the priorities of control programmes, the 
increased accuracy of more detailed mapping strate-
gies will need to be weighed against the survey costs and 
whether the goals of the programme are to accurately 
distribute treatment or to minimise undertreatment.
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Results of geostatistical analyses are consistent with 
other literature, reporting highly focal spatial distribu-
tions of schistosomiasis with large decreases in preva-
lence observed following periods of sustained control [2, 
3]. Across all countries analysed, 6 countries had a mean 
school-level S. haematobium prevalence of 10% or greater 
and only 2 countries had a mean S. mansoni prevalence 
above this threshold. Previous studies have highlighted 
Fig. 3 Monte Carlo maximum likelihood estimates for geostatistical model parameters by species
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the dramatic decrease in schistosomiasis due to effective 
control programmes across this region and successes of 
preventive chemotherapy in substantially reducing dis-
ease burdens [4, 5]. However, due to limitations within 
the datasets analysed, changes over time could not be 
assessed for these data and there remains little under-
standing of how spatial distributions of schistosomia-
sis change following implementation of these control 
measures. While it is likely that patchy implementation 
and variable transmission intensity within existing imple-
mentation units will lead to increased focality, mapping 
surveys need to be evaluated against all plausible spatial 
distributions of schistosomiasis.
As would be expected, the spatial structure of schis-
tosomiasis prevalence strongly influences the accuracy 
of treatment classifications under different mapping 
strategies. Classification accuracy decreases overall with 
increasing focality and spatial variance; these effects are 
particularly pronounced as mean prevalence approaches 
the 10% threshold. However, within these IU-level clas-
sifications, there is substantial heterogeneity in school-
level prevalence, with the potential for large portions of 
schools to be over or undertreated despite correct clas-
sification of IU-level prevalence. Previous studies have 
similarly described substantial numbers of schools not 
assigned to the correct treatment categories under exist-
ing mapping strategies [16, 19]. This emphasises the need 
for control programmes to identify their key treatment 
priorities; in some cases, this may require adopting less 
accurate mapping strategies in favour of minimising the 
numbers of undertreated schools, prioritising sensitivity 
over accuracy.
Equally critically, control programmes are faced with 
choices on how to rationalise scarce resources. Within 
all survey designs considered, increasing the total num-
bers of schools surveyed consistently increases the clas-
sification accuracy. While we present the total costs per 
school surveyed and the cost per correctly identified 
school, cost effectiveness of different survey designs may 
vary substantially by country and diagnostic method. By 
comparing these survey costs with treatment costs for a 
particular region and species, control programmes can 
identify breakpoints at which the cost of treating all indi-
viduals within an IU for the next 5–6 years recommended 
by current guidelines is equal to or less than the costs of 
mapping [6]. For example, if a district has 100,000 SAC 
and treatment costs of USD 0.10 per child, the costs of 
treating all children annually over a 5-year period would 
be USD 50,000. Comparing these costs to the estimated 
survey costs allows control programmes to evaluate 
whether more intensive surveys would be more cost 
effective than treatment of all children within the IU. As 
treatment costs vary substantially by country and region, 
we have not evaluated survey cost effectiveness relative 
to treatment costs but instead provide a framework con-
trol programmes can use to evaluate these costs within 
specific settings. Detailed guidelines have been published 
for estimating both costs of surveys and treatments 
(e.g. [20, 21]), allowing control programmes to develop 
site specific budgets enabling planning of further sur-
vey activities. This may include evaluating economies 
of scale when rolling out large-scale mapping and treat-
ment surveys [22]. This study highlights the importance 
of considering the spatial distributions of risk when 
designing surveys and demonstrates how simulations 
can allow assessment across a wide range of prevalence 
distributions.
Within these simulations, we chose to analyse the 
most commonly used two-stage cluster-based survey 
designs. This analysis assumed that the spatial distribu-
tion of prevalence is unknown with no previously avail-
able geolocated school survey data, optimising sampling 
under a range of prevalence levels and spatial distribu-
tions. While most countries have some baseline survey 
data, many countries lack reliable spatial information on 
prevalence. However, if previous spatial data are avail-
able, alternative sampling strategies may be more cost 
effective and appropriate. For example, geostatistical 
sampling designs utilise information on the spatial struc-
ture of disease prevalence to design more efficient surveys 
[23]. Exploiting spatial correlation between locations, 
this approach uses spatially regulated sampling within a 
model-based geostatistical framework to estimate preva-
lence surfaces. While we only consider methods for clas-
sifying an IU based on the empirical mean as typically 
done by current practice, geostatistical analysis with a 
probabilistic assessment of the IU endemicity would lead 
to a substantial improvement of classification accuracy. 
Table 1 Model parameters used for simulations
Parameter S. haematobium S. mansoni
µ 0.004, 0.008, 0.012, 0.017, 0.024, 0.040, 0.054, 0.079, 0.110, 0.125, 
0.207
0.0005, 0.0013, 0.0026, 0.0038, 0.0048, 0.0058, 
0.0068, 0.0077, 0.0175, 0.0423, 0.0991
φ 30.58, 73.30, 89.71 41.74, 61.64, 114.01
τ2 0.558, 0.977, 1.826 0.312, 0.655, 1.266
σ2 1.458, 3.642, 5.298 1.662, 4.056, 7.058
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Alternatively, when previous data are available, adaptive 
sampling can be used to identify disease hotspots, apply-
ing previous survey information to optimise sampling 
strategies [24]. While these sampling approaches are 
likely to be more efficient than simple random sampling, 
our analysis provides a framework for collecting baseline 
prevalence data with little or no previous geolocated sur-
vey data or in countries without the resources or techni-
cal skills to implement more complex statistical models
Fig. 4 Examples of effects of model parameters on the spatial distribution of prevalence assuming a constant mean prevalence of 0.1 across all 
scenarios
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Despite the utility of this approach in evaluating sam-
pling strategies, this study had several important limita-
tions. Due to the wide range of spatial patterns assessed, 
we chose to conduct unconditional simulations across a 
simulated country. While this allows assessment of spa-
tial distributions of risk representative of those found 
across SSA, the parameters used do not reflect the den-
sity of schools or distributions of administrative districts 
of all countries. Subdistrict definitions vary substantially 
by country, with notable increases in the numbers of 
subnational administrative units within the past dec-
ades [25]. While the consistent numbers of subdistricts 
identified in all districts within our simulated country 
are unlikely to occur in most countries, this provides a 
model of how control programmes could consider sub-
dividing districts with variable numbers of subdistricts. 
Further, as this modelling approach was developed using 
open-source software, this analysis can be easily modified 
Fig. 5 Comparisons of proportions of schools correctly classified sampling 5 schools per district vs 1 or 5 schools per subdistrict for S. haematobium 
(a) and S. mansoni (b)
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Fig. 6 Comparisons of numbers of undertreated schools sampling 5 schools per per district vs 1 or 5 schools per subdistrict for S. haematobium (a) 
and S. mansoni (b) and numbers of overtreated schools for S. haematobium (c) and S. mansoni (d)
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to reflect actual administrative boundaries. Addition-
ally, although this study analysed the largest available 
database of school-based surveys for schistosomiasis, 
this did not allow the evaluation of how spatial patterns 
changed over time or in response to control measures. 
Future studies could evaluate how these spatial distribu-
tions would be expected to change. As surveys are only 
conducted in geographically suitable regions for schis-
tosomiasis transmission, further work could explore the 
application of improved environmental data in defining 
and identifying these regions.
Conclusions
Together, this study demonstrates the importance of 
spatial structure when designing mapping surveys and 
highlights how using finer scale implementation units 
can improve treatment classification accuracy. While 
the most substantial gains in accuracy result from sam-
pling higher numbers of schools at subdistrict levels, 
even sampling the same number of schools stratified by 
subdistrict improves overall accuracy. Effects of these 
survey designs become more pronounced as focality and 
variance increases and prevalence approaches the 10% 
threshold. By considering the specific goals of the control 
programme, costs and likely spatial distributions within 
the study areas, this analysis can be used to guide control 
programmes to develop appropriate sampling strategies.
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Table 2 Cost effectiveness of different sampling strategies for each species, median USD (IQR)
Species Sampling strategy Cost per correctly classified school Cost per adequately 
treated school
S. haematobium 5 schools per district 22.71 (20.47–24.50) 25.26 (20.10–38.05)
1 school per subdistrict 22.16 (20.27–23.96) 28.65 (23.72–37.42)
5 schools per subdistrict 105.82 (98.40–113.63) 116.95 (98.19–153.03)
S. mansoni 5 schools per district 8.07 (7.47–8.98) 17.93 (12.62–39.92)
1 school per subdistrict 8.04 (7.54–8.69) 16.36 (12.72–23.80)
5 schools per subdistrict 39.32 (37.19–42.30) 67.73 (54.10–103.62)
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